phosphonoacetic acid has been researched along with flucytosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Huber, BE; Wei, K | 1 |
Beltinger, C; Buechele, B; Debatin, KM; Simmet, T; Unger, MM; Ushmorov, A; Wahl, J | 1 |
Cai, S; Du, J; Jiang, J; Liu, L; Liu, Q; Sung, KL; Yan, X; Yang, L; Yang, Y; Yu, S; Zhang, H | 1 |
4 other study(ies) available for phosphonoacetic acid and flucytosine
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Cytosine deaminase gene as a positive selection marker.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; Cell Cycle; Cell Division; Cell Line, Transformed; Cell Survival; Culture Media; Cytosine; Cytosine Deaminase; Flucytosine; Gene Expression; Genes, Bacterial; Genetic Markers; Inosine; Mice; Nucleoside Deaminases; Phosphonoacetic Acid; Rats; Transfection; Tumor Cells, Cultured | 1996 |
Enriching suicide gene bearing tumor cells for an increased bystander effect.
Topics: Animals; Aspartic Acid; Bystander Effect; Cell Line, Tumor; Cytosine Deaminase; Female; Flucytosine; Genetic Therapy; Mice; Pentosyltransferases; Phosphonoacetic Acid; Plasmids | 2007 |
Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adult; Animals; Antigens, CD; Antimetabolites; Aspartic Acid; Bone Marrow Cells; Cell Differentiation; Cell Survival; Cell Transformation, Neoplastic; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Gene Expression; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Kruppel-Like Transcription Factors; Lentivirus; Luciferases; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phosphonoacetic Acid; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Response Elements; Stromal Cells; Telomerase; Transduction, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Young Adult | 2010 |